tetrabenazine has been researched along with Alzheimer Disease in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Leitinger, G; Maurer, C; Radulović, S; Sunkara, S | 1 |
Choi, Y; Chung, SJ; Lee, PH; Lee, S; Lee, YH; Sohn, YH; Ye, BS; Yoo, H; Yun, M | 1 |
Adler, CH; Beach, TG; Belden, CM; Driver-Dunckley, E; Dugger, BN; Gupta, HV; Joshi, AD; Liebsack, C; Mehta, SH; Mintun, MA; Pontecorvo, MJ; Sabbagh, MN; Serrano, GE; Shill, HA; Siderowf, A; Sue, LI | 1 |
Adler, CH; Arora, A; Galasko, D; Joshi, AD; Liebsack, C; Lu, M; Mintun, MA; Pontecorvo, MJ; Sabbagh, MN; Shill, HA; Siderowf, A; Skovronsky, DM | 1 |
Barthel, H; Bullich, S; Catafau, AM; Ghetti, B; Hoffmann, A; Ironside, JW; Leverenz, J; Sabri, O; Schulz-Schaeffer, WJ; Seibyl, JP | 1 |
Frey, KA; Gilman, S; Junck, L; Koeppe, RA; Wernette, K | 1 |
Ackermann, U; Chételat, G; Drago, J; Gong, S; Jones, G; Kung, HF; Masters, CL; Mulligan, RS; O'Keefe, G; Okamura, N; Pejoska, S; Rowe, CC; Skovronsky, DM; Tochon-Danguy, H; Villemagne, VL | 1 |
Chételat, G; Drago, J; Jones, G; Kung, HF; Masters, CL; Mulligan, RS; O'Keefe, G; Okamura, N; Pejoska, S; Pontecorvo, M; Rowe, CC; Skovronsky, DM; Villemagne, VL | 1 |
An, H; Gilman, S; Giordani, B; Heumann, M; Junck, L; Koeppe, RA; Little, R; Persad, C; Wernette, K | 1 |
Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S | 1 |
Agid, Y; Anglade, P; Brandel, JP; Duyckaerts, C; Hirsch, EC; Javoy-Agid, F; Lehéricy, S; Scherman, D; Villares, J | 1 |
Frey, KA; Kilbourn, MR; Wieland, DM | 1 |
1 review(s) available for tetrabenazine and Alzheimer Disease
Article | Year |
---|---|
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine | 2021 |
11 other study(ies) available for tetrabenazine and Alzheimer Disease
Article | Year |
---|---|
Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2020 |
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Dopamine; Ethylene Glycols; Fatal Outcome; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2021 |
PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Dopamine; Drug Combinations; Ethylene Glycols; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2014 |
Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?
Topics: Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cerebellum; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Male; Molecular Imaging; Organ Specificity; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tetrabenazine; Tissue Distribution | 2016 |
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine | 2008 |
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain Mapping; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2011 |
Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Aniline Compounds; Brain Mapping; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; Diagnosis, Differential; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Tetrabenazine; Thiazoles; Vesicular Monoamine Transport Proteins | 2012 |
Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Binding Sites; Biogenic Monoamines; Carbon Isotopes; Corpus Striatum; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed | 2004 |
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine | 2005 |
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Binding Sites; Biogenic Monoamines; Corpus Striatum; Female; Humans; Male; Middle Aged; Parkinson Disease; Reference Values; Tetrabenazine; Tritium | 1994 |
Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
Topics: Acetylcholine; Alzheimer Disease; Brain; Carbon Radioisotopes; Carrier Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Neuromuscular Depolarizing Agents; Neurons; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Piperidines; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tritium; Vesicular Acetylcholine Transport Proteins; Vesicular Biogenic Amine Transport Proteins; Vesicular Transport Proteins | 1998 |